Deltamethrin (with Xylene) Formulation

Hazard statements (CLP)

H226, H302, H302+H332, H304, H315, H317, H319, H332, H335, H340, H350, H361fd, H373, H400, H410

Code

Statements

H226

Flammable liquid and vapour

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger

Hazard statements

H226 Flammable liquid and vapour. H302 + H332 Harmful if swallowed or if inhaled. H304 May be fatal if swallowed and enters airways. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H340 May cause genetic defects. H350 May cause cancer. H361fd Suspected of damaging fertility. Suspected of damag- ing the unborn child. H373 May cause damage to organs through prolonged or repeated exposure. H410 Very toxic to aquatic life with long lasting effects. EUH430 May cause endocrine disruption in the envi- ronment

Prevention

P201 Obtain special instructions before use. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.

Response

P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P391 Collect spillage.

Hazardous Ingredients

Ethylbenzene Xylene deltamethrin (ISO) Solvent naphtha (petroleum), light aromatic Restricted to professional users.

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

This substance/mixture contains components considered to have endo- crine disrupting properties for environment, according to REACH Article 57(f), Commission Regu- lation (EU) 2018/605 or Commission Delegated Regulation (EU) 2017/2100.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Cutaneous sensations may occur, such as burning or stinging on the face and mucosae. Howev- er, these sensations cause no lesions and are of a transitory nature (max. 24 hours). Vapours may form explosive mixture with air.

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) Flammable liquids, Category 3 H226: Flammable liquid and vapour. Acute toxicity, Category 4 H302: Harmful if swallowed. Acute toxicity, Category 4 H332: Harmful if inhaled. Skin irritation, Category 2 H315: Causes skin irritation. Eye irritation, Category 2 H319: Causes serious eye irritation. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Germ cell mutagenicity, Category 1B H340: May cause genetic defects. Carcinogenicity, Category 1B H350: May cause cancer. Reproductive toxicity, Category 2 H361fd: Suspected of damaging fertility. Suspected of damaging the unborn child. Specific target organ toxicity - single ex- H335: May cause respiratory irritation. posure, Category 3 Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2 longed or repeated exposure. Aspiration hazard, Category 1 H304: May be fatal if swallowed and enters air- ways. Short-term (acute) aquatic hazard, Cate- H400: Very toxic to aquatic life. gory 1 Long-term (chronic) aquatic hazard, Cat- H410: Very toxic to aquatic life with long lasting egory 1 effects. Endocrine disruptor for environment, EUH430: May cause endocrine disruption in the Category 1 environment